We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomedical Research Consortium for Regenerative Medicine Under Construction

By LabMedica International staff writers
Posted on 04 May 2010
A new US$126 million, 13,536-m2 biomedical research "collaboratory” will pursue joint projects by its members and collaboration partners to invent tools and technologies intended to advance research into stem cells, and to discover and develop innovative diagnostics and therapies. More...


The Sanford Consortium for Regenerative Medicine, a consortium of four world leaders in life sciences research (the Salk Institute for Biological Studies, The Scripps Research Institute (La Jolla, CA, USA), Sanford-Burnham Medical Research Institute (La Jolla), and the University of California, San Diego, hosted an official groundbreaking ceremony on March 26, 2010, in La Jolla, CA, USA.

The consortium, formed in 2006 to build and operate the biomedical research laboratory, consists of these four leading medical institutions--all internationally known for their exceptional contributions to medical research and treatments.

The Sanford Consortium for Regenerative Medicine will be a preeminent research center to develop the next generation of breakthrough cures, therapies, diagnostics, research tools, and technologies in stem cell research. The consortium's key research focuses on stem cell growth and differentiation, neuroscience, cardiovascular biology, blood cell development, and vision science.

The Sanford Consortium for Regenerative Medicine is designed as one of the most forward-thinking laboratories, effectively fostering informal collaboration and communication among researchers in a synergistic environment. Shared two-story break rooms interconnect all levels and encourage interaction among researchers. Approximately 330 investigators and associated staff will occupy the open labs, offices, and specialized core labs. Conference facilities include a 150-seat auditorium, large divisible conference room and a café.

Related Links:
Sanford Consortium for Regenerative Medicine


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.